Drugs / Polyethylene glycol 3350-electrolyte solution
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT01283152 Comparator | Jan 2011 → Jun 2012 | cirrhosis of liver, hepatic encephalopathy | University of Texas Southwestern Medical Center | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Polyethylene glycol 3350-electrolyte solution | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01283152 ↗ |
| Known as | PEG | “OBJECTIVE: To compare polyethylene glycol 3350-electrolyte solution (PEG) and lactulose treatments in patients with cirrhosis admitted to the hospital for HE.” PMID 25243839 ↗ Nov 2014 |